With the risk for tenofovir nephrotoxicity in mind, researchers investigated the impact of treatment with sofosbuvir/ledipasvir with or without tenofovir in patients with HCV/HIV coinfection.
Comorbidities like hepatitis C virus, renal, liver, and chronic pulmonary diseases significantly boosted the risk of hospitalization and costs of patients with HIV, a recent study suggests.
The International Antiviral Society–USA Panel has released a set of updated recommendations for the treatment of patients with HIV, including universal screening for anyone who has been sexually active and...
Data about the prevalence of sleep apnea among individuals with HIV and HF are scarce, although sleep apnea is common among those with HF. A new study investigated.
A new study presented at AIDS 2018 shed light on the incidence of hepatitis C virus re-infection among men who have sex with men and were using pre-exposure prophylaxis. The findings may lead to better...
Following an analysis of survey data from nearly 12,000 respondents, the Centers for Disease Control and Prevention have released a report on the frequency of HIV testing among various patient populations...
Although PrEP use has increased rapidly in various parts of the world, its effect on condom use among gay and bisexual men is not well characterized. In a new study, researchers explored trends in condom...
Recent research in AIDS Care found that VA patients with HIV had better treatment retention and viral suppression when taking a single-tablet regimen compared with a multi-tablet regimen.
The authors of a recent study aimed to investigate the effectiveness of an emerging cardiovascular risk biomarker in predicting CVD risk specifically among patients with HIV infection.
